Abraxis BioScience Inc.

Abraxis BioScience Inc. reported fourth quarter net income of $28.4 million, up nearly 10 fold from the same period a year earlier. Revenue for the Los Angeles-based biotech firm surged 76 percent to $257 million ...

COPYRIGHT 2007 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:	Earnings Roundup
Publication:	Los Angeles Business Journal
Date:	Mar 5, 2007
Words:	36
Previous Article:	21st Century Insurance Group.(Earnings Roundup)(Brief article)
Next Article:	Guitar Centers Inc. reported a fourth-quarter loss of $40 million.(Earnings Roundup)(Financial report)
Topics:	Biotechnology industries Company sales and earnings Biotechnology industry Company sales and earnings

Related Articles
FDA approval fails to win American Pharmaceutical support.(American Pharmaceutical Partners Inc.'s stock performance forecast)
Abraxis to open biopharmaceutical campus in Culver City.(Abraxis BioScience Inc. )(Brief article)
Abraxis waiting for cancer treatment to cure its Wall Street woes.(Corporate Focus)
Weekly top gainers.(THE LABJ STOCK INDEX: TRACKING 200 SELECTED LOS ANGELES COUNTY-BASED COMPANIES)(Statistical table)
Drug tests.(Abraxis BioScience Inc. told to conduct a well controlled randomized clinical trial)(Brief article)
Drug approval.(News of the Week)(Abraxis BioScience Inc)(Brief article)
Abraxis loses civil suit.(HEALTH CARE & BIOTECH)
Biotech/biomed companies: ranked by total employment.(The List)(Company rankings)
Earnings roundup.(News of the Week)